Table 2.
Serious Adverse Events
| Event Type | Treatment Recovery Period* (n Events) | 3 mo† (n Events) | 6 mo‡ (n Events) | 12 mo§ (n Events) |
|---|---|---|---|---|
| Device-related‖ | 0 | 0 | 0 | 0 |
| Procedure-related‖ | ||||
| COPD exacerbation | 1 | 1 | 0 | 0 |
| Mucosal scarring | 1 | 0 | 0 | 0 |
| Pneumonia | 1 | 0 | 0 | 0 |
| Unrelated to device or procedure | ||||
| Atrial fibrillation | 1 | 0 | 0 | 0 |
| COPD exacerbation | 0 | 1 | 1 | 3 |
| Erysipelas | 0 | 0 | 1 | 0 |
| Femoral artery stenosis | 0 | 0 | 1 | 1 |
| Lung nodule | 0 | 0 | 0 | 1 |
| Musculoskeletal injury | 0 | 0 | 0 | 1 |
| Pyelonephritis | 0 | 0 | 0 | 1 |
Definition of abbreviation: COPD = chronic obstructive pulmonary disease.
There were a total of 16 events in 11 patients. One patient experienced 2 COPD exacerbations in separate time intervals.
Thirty days after either bronchial rheoplasty procedure.
Follow-up period through 3 months after treatment 2, excluding either treatment recovery period.
Follow-up period between 3 months and 6 months after treatment 2.
Follow-up period between 6 months and 12 months after treatment 2.
Events are considered device-related or procedure-related if judged by the treating investigator to be possibly, probably, or definitely related to the device or procedure, respectively.